Parametrica Management’s Idexx Laboratories IDXX Stock Holding History

Parametrica Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-502	Closed	-$239K	–	138
2021 Q1	$239K	Sell	502 -96	-16%	-$48.1K	0.11%	131
2020 Q4	$299K	Buy	+598	New	+$268K	0.18%	104
2014 Q3	–	Sell	-3,154	Closed	-$211K	–	83
2014 Q2	$211K	Buy	+3,154	New	+$201K	1.6%	37

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Parametrica Management's IDXX Position: Q2 2021 in Review

Parametrica Management sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 502 shares — an estimated $239K sold.

Parametrica Management first reported a position in IDXX in Q2 2014 and held it in 3 quarters. The position peaked at $299K in Q4 2020. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

Parametrica Management reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
Parametrica Management sold 502 Idexx Laboratories shares in Q2 2021, an estimated $239K.
Parametrica Management first reported a position in Idexx Laboratories in Q2 2014 and held it in 3 quarters.
Parametrica Management's Idexx Laboratories position peaked at $299K in Q4 2020.
1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.